characterization of the ivs17bta microsatellite marker and six ctfr gene mutations in 21 cuban families with cystic fibrosis
Clicks: 222
ID: 161148
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Star Article
30.0
/100
222 views
39 readers
AI Quality Assessment
Not analyzed
Readership in this journal
StarRanked #5 of 6 articles by views in agrekon
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Cystic fibrosis is an autosomal recessive disease. Its incidence in Cuba is 1 in 5000 live births. The molecular cause underlying this disease is related to mutations in the regulatory gene encoding the cystic fibrosis transmembrane regulator (CFTR). In this study, the techniques for the study of IVS17bTA microsatellite marker were standardized, and the most frequent mutations in the CFTR gene were also detected for 21 Cuban families. Polymerase chain reaction, agarose and polyacrylamide (plus silver staining) gel electrophoresis techniques were used for both, identification of mutations and microsatellite standardization. Among the 22 Cuban patients, seven were found homozygous, four compound heterozygous and 11 with a single mutation so, 33 chromosomes were molecularly characterized for the 75 %. Twelve allelic variants were found for the IVS17bTA microsatellite; alleles 31 and 7 the most frequent ones. Alleles 31 and 46 were associated to the F508del and R334W mutations, respectively. Among the 21 families, 18 were completely informative for the IVS17bTA microsatellite marker, accounting for 85.7 %. This study helped to complete the diagnosis in those patients in which the responsible mutations in one or both chromosomes had not yet been identified. Besides, we were also able to identify mutations associated with different alleles of the marker without gene sequencing, also helping to decrease the cost of screening.
| Reference Key |
gonzlezbiotecnologacharacterization
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Laura González;Teresa Collazo;Yulia Clark;Manuel Gómez;Lídice Reyes |
| Journal | agrekon |
| Year | Year not found |
| DOI |
DOI not found
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.